Trial Profile
Antidrug antibody formation in patients with plaque psoriasis taking adalimumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics